SOD1 and amyotrophic lateral sclerosis: Whether the poorly CNS-penetrant P2X7 antagonist Brilliant Blue G, which likewise slows disease progression in ALS SOD1G93A mice [71], also impairs P2X7-mediated aggregated SOD1 release remains unknown.